Artificial Pancreas: first clinical trials in Argentina

"The first clinical trials using an Artificial Pancreas (AP) in Latin America have been defined in 2 stages. The first stage was carried out in November 2016 with the UVA controller (developed by the Center for Diabetes Technology and already clinically tested), and the second will be performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Peña, Ricardo, Colmegna, Patricio, Grosembacher, Luis, Breton, Marc, De Battista, Hernán, Garelli, Fabricio, Belloso, Waldo H., Campos-Náñez, Enrique, Simonovich, Ventura, Beruto, Valeria, Scibona, Paula, Cherñavvsky, Daniel
Formato: Ponencias en Congresos acceptedVersion
Lenguaje:Inglés
Publicado: 2019
Materias:
Acceso en línea:http://ri.itba.edu.ar/handle/123456789/1763
Aporte de:
id I32-R138-123456789-1763
record_format dspace
spelling I32-R138-123456789-17632022-12-07T14:13:41Z Artificial Pancreas: first clinical trials in Argentina Sánchez-Peña, Ricardo Colmegna, Patricio Grosembacher, Luis Breton, Marc De Battista, Hernán Garelli, Fabricio Belloso, Waldo H. Campos-Náñez, Enrique Simonovich, Ventura Beruto, Valeria Scibona, Paula Cherñavvsky, Daniel ORGANOS ARTIFICIALES PANCREAS ENSAYOS CLINICOS DIABETES CONTROL EN MODO DESLIZANTE INSULINA GLUCOSA "The first clinical trials using an Artificial Pancreas (AP) in Latin America have been defined in 2 stages. The first stage was carried out in November 2016 with the UVA controller (developed by the Center for Diabetes Technology and already clinically tested), and the second will be performed during the first semester of 2017 with the ARG (Automatic Regulation of Glucose) algorithm (developed by ITBA, UNQ, and UNLP in Argentina). Both tests are based on the DiAs (Diabetes Assistant) from the UVA, and are performed in the HIBA on 5 patients with Type 1 Diabetes Mellitus (T1DM), for 36 hours. For the first stage, Open-Loop (OL) insulin boluses were applied before meals and patient's physical activity was included. On the other hand, for the second stage, patients will not be involved in physical activity, but no OL insulin boluses will be injected before meals. In this work, experimental results from the first stage with the UVA controller, and preliminary results with the ARG control algorithm tested on the UVA/Padova simulator are presented. Due to the final paper deadline, the experimental results from the second stage are not included here, but will be presented at the IFAC World Congress." 2019-09-20T15:55:52Z 2019-09-20T15:55:52Z 2017-07 Ponencias en Congresos info:eu-repo/semantics/acceptedVersion 2405-8963 http://ri.itba.edu.ar/handle/123456789/1763 en info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ifacol.2017.08.1151 info:eu-repo/grantAgreement/Fundación Cellex/ES. Barcelona info:eu-repo/grantAgreement/UVA/US. Virginia application/pdf Argentina
institution Instituto Tecnológico de Buenos Aires (ITBA)
institution_str I-32
repository_str R-138
collection Repositorio Institucional Instituto Tecnológico de Buenos Aires (ITBA)
language Inglés
topic ORGANOS ARTIFICIALES
PANCREAS
ENSAYOS CLINICOS
DIABETES
CONTROL EN MODO DESLIZANTE
INSULINA
GLUCOSA
spellingShingle ORGANOS ARTIFICIALES
PANCREAS
ENSAYOS CLINICOS
DIABETES
CONTROL EN MODO DESLIZANTE
INSULINA
GLUCOSA
Sánchez-Peña, Ricardo
Colmegna, Patricio
Grosembacher, Luis
Breton, Marc
De Battista, Hernán
Garelli, Fabricio
Belloso, Waldo H.
Campos-Náñez, Enrique
Simonovich, Ventura
Beruto, Valeria
Scibona, Paula
Cherñavvsky, Daniel
Artificial Pancreas: first clinical trials in Argentina
topic_facet ORGANOS ARTIFICIALES
PANCREAS
ENSAYOS CLINICOS
DIABETES
CONTROL EN MODO DESLIZANTE
INSULINA
GLUCOSA
description "The first clinical trials using an Artificial Pancreas (AP) in Latin America have been defined in 2 stages. The first stage was carried out in November 2016 with the UVA controller (developed by the Center for Diabetes Technology and already clinically tested), and the second will be performed during the first semester of 2017 with the ARG (Automatic Regulation of Glucose) algorithm (developed by ITBA, UNQ, and UNLP in Argentina). Both tests are based on the DiAs (Diabetes Assistant) from the UVA, and are performed in the HIBA on 5 patients with Type 1 Diabetes Mellitus (T1DM), for 36 hours. For the first stage, Open-Loop (OL) insulin boluses were applied before meals and patient's physical activity was included. On the other hand, for the second stage, patients will not be involved in physical activity, but no OL insulin boluses will be injected before meals. In this work, experimental results from the first stage with the UVA controller, and preliminary results with the ARG control algorithm tested on the UVA/Padova simulator are presented. Due to the final paper deadline, the experimental results from the second stage are not included here, but will be presented at the IFAC World Congress."
format Ponencias en Congresos
acceptedVersion
author Sánchez-Peña, Ricardo
Colmegna, Patricio
Grosembacher, Luis
Breton, Marc
De Battista, Hernán
Garelli, Fabricio
Belloso, Waldo H.
Campos-Náñez, Enrique
Simonovich, Ventura
Beruto, Valeria
Scibona, Paula
Cherñavvsky, Daniel
author_facet Sánchez-Peña, Ricardo
Colmegna, Patricio
Grosembacher, Luis
Breton, Marc
De Battista, Hernán
Garelli, Fabricio
Belloso, Waldo H.
Campos-Náñez, Enrique
Simonovich, Ventura
Beruto, Valeria
Scibona, Paula
Cherñavvsky, Daniel
author_sort Sánchez-Peña, Ricardo
title Artificial Pancreas: first clinical trials in Argentina
title_short Artificial Pancreas: first clinical trials in Argentina
title_full Artificial Pancreas: first clinical trials in Argentina
title_fullStr Artificial Pancreas: first clinical trials in Argentina
title_full_unstemmed Artificial Pancreas: first clinical trials in Argentina
title_sort artificial pancreas: first clinical trials in argentina
publishDate 2019
url http://ri.itba.edu.ar/handle/123456789/1763
work_keys_str_mv AT sanchezpenaricardo artificialpancreasfirstclinicaltrialsinargentina
AT colmegnapatricio artificialpancreasfirstclinicaltrialsinargentina
AT grosembacherluis artificialpancreasfirstclinicaltrialsinargentina
AT bretonmarc artificialpancreasfirstclinicaltrialsinargentina
AT debattistahernan artificialpancreasfirstclinicaltrialsinargentina
AT garellifabricio artificialpancreasfirstclinicaltrialsinargentina
AT bellosowaldoh artificialpancreasfirstclinicaltrialsinargentina
AT camposnanezenrique artificialpancreasfirstclinicaltrialsinargentina
AT simonovichventura artificialpancreasfirstclinicaltrialsinargentina
AT berutovaleria artificialpancreasfirstclinicaltrialsinargentina
AT scibonapaula artificialpancreasfirstclinicaltrialsinargentina
AT chernavvskydaniel artificialpancreasfirstclinicaltrialsinargentina
_version_ 1765660867339223040